INSIDER · CIK 1821189
Mainolfi Nello
Chief Executive Officer, Director at Kymera Therapeutics, Inc. (KYMR)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$3.4MSold on the market
1Companies
Oct 1, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 202617:20 | Oct 1, 2026 | KYMRKymera Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $113.80 | −30,000 | 666,568 | -4% | −$3.4M | ||
| Oct 1, 202617:20 | Oct 1, 2026 | KYMRKymera Therapeutics, Inc. | Chief Executive Officer, Director | M · Exercise10b5-1 | $2.08 | +30,000 | 696,568 | +5% | $62K |